Education
About Us
Working with TipRanks
Follow Us
NDT Pharmaceuticals, Inc. (NDTP)
OTHER OTC:NDTP
Total Valuation
NDT Pharmaceuticals has a market cap or net worth of $163.20M. The enterprise value is $120.00M.
Market Cap$163.20M
Enterprise Value$120.00M
Share Statistics
NDT Pharmaceuticals has 160,004,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding160,004,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NDT Pharmaceuticals’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -24.88%.
Return on Equity (ROE)-0.78
Return on Assets (ROA)-0.55
Return on Invested Capital (ROIC)-24.88%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee0.00
Profits Per Employee-79.03K
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NDT Pharmaceuticals is ―. NDT Pharmaceuticals’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio96.87
Price to Fair Value96.87
Price to FCF-551.82
Price to Operating Cash Flow-621.78K
PEG Ratio0.00
Income Statement
In the last 12 months, NDT Pharmaceuticals had revenue of 0.00 and earned -79.03K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-25.17K
Pretax Income-79.03K
Net Income-79.03K
EBITDA88.87K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -193.00 and capital expenditures 3.00, giving a free cash flow of -190.00 billion.
Operating Cash Flow-193.00
Free Cash Flow-190.00
Free Cash Flow per Share>-0.01
Dividends & Yields
NDT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.24
52-Week Price Change1257.14%
50-Day Moving Average1.22
200-Day Moving Average0.66
Relative Strength Index (RSI)46.54
Average Volume (3m)12.23K
Important Dates
NDT Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
NDT Pharmaceuticals as a current ratio of 0.02, with Debt / Equity ratio of 0.00%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.00
Net Debt to EBITDA>-0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NDT Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NDT Pharmaceuticals EV to EBITDA ratio is 110.27, with an EV/FCF ratio of -551.78.
EV to Sales0.00
EV to EBITDA110.27
EV to Free Cash Flow-551.78
EV to Operating Cash Flow-551.69
Balance Sheet
NDT Pharmaceuticals has $647.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $647.00 billion.
Cash & Marketable Securities$647.00
Total Debt$0.00
Net Cash$647.00
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NDT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―